Meredith Fisher
Co-founding CEO and Director at Violet Therapeutics
Cambridge, Massachusetts
Overview
Work Experience
Co-founding CEO and Director
2022 - Current
Violet Therapeutics is a pre-clinical stage company leveraging first-in-class platforms to identify, map, and mine the cellular connectome.
Raised $10,600,000.00 from Mass General Brigham Ventures, Ono Venture Investment, UTEC - The University of Tokyo Edge Capital Partners and Dementia Discovery Fund.
Partner, Mass General Brigham Ventures
2016
Mass General Brigham Ventures is an early-stage venture capital firm founded in 2008 to advance new science and technology based on discovery and invention originating from Mass General Brigham. The fund invests in medical innovations created by MGB’s world-class research hospitals. We invest in leading-edge life science technologies with the goal of bringing discoveries, inventions and innovations from MGB to market for the benefit of patients worldwide. Portfolio: FireCyte, Violet, Nocion, Mediar, Amolyt Pharma, ZielBio, Scorpion and Claris Bio
Mass General Brigham Ventures is the venture capital arm of Mass General Brigham that invests in early-stage companies.
Co-founding CEO and Director
2019 - 2023
Mediar is a pre-clinical stage biotechnology company developing therapeutics for the treatment of fibrosis.
Raised $105,000,000.00 from Pureos Bioventures, Novartis Venture Fund, Mass General Brigham Ventures, Ono Venture Investment, Mission BioCapital, Pfizer Venture Investments, Gimv, Sofinnova Partners, Eli Lilly & Company Foundation and Bristol-Myers Squibb.
Director, Private Investments
2013 - 2015
Bracebridge manages assets for a diverse, sophisticated, global investor base that includes endowments, foundations, pensions, and high net.
Head, Business Development
2012 - 2013
Ginkgo Bioworks designs custom microbes for customers across multiple markets, developing new organisms that replace technology with biology. www.ginkgobioworks.com
Ginkgo Bioworks is a developer of biological engineering products and custom microbes across multiple markets.
Raised $1,575,403,063.00 from Bill & Melinda Gates Foundation, Bill & Melinda Gates Foundation, Centers for Disease Control and Prevention and Agriculture and Food Research Initiative.
Senior Director of Technology & Business Development at Enlight Biosciences
2009 - 2012
Enlight is a venture creation firm founded by PureTech Ventures.
Associate Scientist
2001 - 2002
Associate Scientist
1998 - 2000